A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Two-Period, Parallel-group Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients.

NCT00140946 Phase 4 COMPLETED

A study to assess the clinical effect of montelukast sodium with concomitant administration of inhaled budesonide in asthmatic patients.

Details

Lead sponsor	Organon and Co
Phase	Phase 4
Status	COMPLETED
Enrolment	546
Start date	1998-03
Completion	2000-10

Conditions

• Asthma

Interventions

• MK0476; montelukast sodium/Duration of Treatment: 16 weeks
• Comparator: placebo / Duration of Treatment: 16 weeks

Primary outcomes

• Percentage of days of asthma exacerbations